Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 29.11B | 29.11B | 28.84B | 26.91B | 24.96B | 23.80B |
Gross Profit | 1.98B | 1.79B | 2.10B | 754.80M | 1.06B | 600.31M |
EBITDA | 1.07B | 1.37B | 1.53B | 617.62M | 569.32M | -475.15M |
Net Income | 238.02M | 2.05B | 213.91M | -400.58M | -650.04M | -2.23B |
Balance Sheet | ||||||
Total Assets | 31.12B | 31.06B | 31.12B | 30.07B | 30.57B | 29.75B |
Cash, Cash Equivalents and Short-Term Investments | 10.96B | 11.62B | 10.96B | 9.55B | 12.05B | 10.87B |
Total Debt | 13.64B | 12.62B | 13.49B | 13.51B | 13.26B | 12.15B |
Total Liabilities | 18.76B | 16.82B | 18.76B | 17.81B | 17.69B | 16.08B |
Stockholders Equity | 12.37B | 14.24B | 12.37B | 12.26B | 12.89B | 13.67B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -794.54M | 1.09B | -2.46B | 476.90M | -2.52B |
Operating Cash Flow | 0.00 | 254.63M | 1.99B | 7.28M | 1.72B | -857.32M |
Investing Cash Flow | 0.00 | 1.74B | -708.82M | -2.59B | -1.51B | -1.27B |
Financing Cash Flow | 0.00 | -1.10B | -255.61M | -20.18M | 917.86M | 2.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥3.06B | 8.19 | 2.48% | 2.33% | -0.96% | ||
75 Outperform | ¥3.12B | 9.80 | 3.04% | 4.85% | 4751.70% | ||
68 Neutral | ¥8.78B | 20.09 | ― | 10.60% | 15.70% | ||
64 Neutral | ¥3.92B | 10.64 | ― | 15.25% | 93.03% | ||
63 Neutral | ¥5.97B | 2.92 | 3.24% | 0.91% | 856.87% | ||
58 Neutral | ¥5.60B | 7.85 | 3.36% | 8.95% | ― | ||
52 Neutral | $7.52B | 0.21 | -63.76% | 2.30% | 16.15% | 0.89% |